Circadian Biology Newsletter
Issue #1September 8, 20257 studies

Morning cancer treatment works better—and your body clock shapes heart health

Your circadian rhythm isn't just about sleep—it's running the show on everything from cancer treatment success to heart disease risk. This week's research reveals how timing could be medicine's next frontier.

🕐 Cancer Treatment Timing Could Save Lives

  • 450 lung cancer patients receiving pembrolizumab (an immunotherapy drug) showed dramatically different outcomes based on when they got their first infusion

  • Those who received treatment before 11 AM lived a median of 43.7 months compared to 32.4 months for afternoon patients—an 11-month survival advantage

  • Morning treatment came with a trade-off: 26.2% experienced severe side effects versus 13.6% in the afternoon group

Why it matters: This suggests that something as simple as scheduling could significantly improve cancer outcomes. The timing may work by aligning treatment with natural immune system rhythms that peak in the morning.

Key Findings

🧬 DNA Methylation Controls Heart Clock Genes

  • Scientists identified that heart-protecting circadian genes REV-ERBα/β and E4BP4 regulate cardiac function through DNA methylation patterns

  • These genes control when heart cells repair themselves and manage energy metabolism on a 24-hour cycle

  • Disrupting these molecular clocks is linked to cardiovascular disease, but the genes are druggable targets for future therapies

💡 This could explain why heart attacks peak at certain times of day and may lead to time-based heart treatments.
🎖️ Top 10% journal 🔗 Journal of molecular and cellular cardiology 🗓️ Sep 4

⏰ Brain Cancer Cells Have Daily Vulnerability Windows

  • Glioblastoma brain tumors show daily rhythms in MGMT protein levels (a DNA repair enzyme that blocks chemotherapy)

  • Patient biopsies revealed MGMT peaks at midday, creating a predictable window when tumors are most vulnerable to treatment

  • Mathematical modeling suggests timing chemotherapy after MGMT peaks could significantly enhance DNA damage to cancer cells

💡 Timing brain cancer treatment to cellular rhythms may dramatically improve outcomes for this deadly disease.
🔗 Research square 🗓️ Sep 5

🍽️ Brain's Appetite Control Follows Precise Daily Schedule

  • Specific neurons in mice brains that respond to the hunger hormone ghrelin only control eating during mid-rest periods (equivalent to human afternoon)

  • Stimulating these GHSR-expressing neurons during this window increased food intake, while blocking them reduced eating and body weight

  • The same neurons had no effect on appetite when activated at other times of day

💡 This reveals why meal timing affects weight gain and could inform when appetite-suppressing treatments work best.
🥈 Top 2% journal 🔗 Cell reports 🗓️ Sep 4

🩸 Blood Test Detects Broken Body Clocks in Cancer Survivors

  • Researchers developed BloodCCD, a test measuring 42 genes in blood samples that reveals circadian rhythm disruption

  • 201 cancer survivors with insomnia had significantly worse BloodCCD scores compared to 100 healthy controls

  • Insomnia severity directly correlated with the degree of circadian disruption detected in blood

💡 This could provide the first objective test for circadian-related sleep problems in cancer patients.
🔗 BJC reports 🗓️ Sep 3

🌅 Evening People Face Higher Blood Pressure Risk

  • Among 945 middle-aged and older adults, those with evening chronotypes had 60% higher odds of hypertension compared to morning types

  • Evening chronotypes also had higher levels of cholesterol, LDL cholesterol, and uric acid

  • The relationship between chronotype and blood pressure showed a non-linear pattern, with risk increasing more sharply at the evening extreme

💡 Being a night owl may carry measurable cardiovascular risks that could be addressed through circadian interventions.
Top 20% journal 🔗 Nature and science of sleep 🗓️ Sep 3

🧠 Circadian Disruption Accelerates Cellular Aging

  • The CLOCK protein, central to circadian rhythms, plays a dual role in cellular aging: supporting DNA repair in healthy cells while being hijacked by cancer cells to avoid senescence

  • In normal cells, CLOCK activates repair factors like XPA and modulates metabolism to support cellular rejuvenation

  • When disrupted by factors like gut microbiota signals, the CLOCK-BMAL1 complex loses its protective effects against aging

💡 This suggests targeting circadian proteins could be a new approach to slow aging and prevent cancer.
Top 20% journal 🔗 Biogerontology 🗓️ Sep 3

Implications

These findings paint a picture of the circadian system as a master regulator of health, controlling everything from cancer treatment success to heart disease risk through precise molecular timing. The research suggests we may be missing major therapeutic opportunities by ignoring when treatments are given and could revolutionize medicine through chronotherapy—treating diseases according to the body's natural rhythms.

Studies in this issue

Primary sources used for this newsletter.

  1. Timing of first pembrolizumab treatment and long-term results in non-small cell lung cancer
    main storyEuropean journal of cancer (Oxford, England : 1990)2025-09-03PMID 40902339
  2. How the body’s internal clock affects cell aging
    key findingBiogerontology2025-09-03PMID 40900376
  3. Daily rhythm regulators REV-ERBα/β and E4BP4 control heart function
    key findingJournal of molecular and cellular cardiology2025-09-04PMID 40907654